Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy
- PMID: 19875549
- PMCID: PMC2811461
- DOI: 10.2337/dc09-S307
Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy
Comment in
-
Nonpharmacologic therapy and exercise in the prevention of type 2 diabetes.Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S189-93. doi: 10.2337/dc09-S308. Diabetes Care. 2009. PMID: 19875550 Free PMC article. Review.
References
-
- Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047– 1053 - PubMed
-
- Alberti KGMM: The costs of non-insulin-dependent diabetes mellitus. Diabet Med 1997; 14: 7– 9 - PubMed
-
- De Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M: Cause-specific mortality in type 2 diabetes: the Verona diabetes study. Diabetes Care 1999; 22: 756– 761 - PubMed
-
- American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31: 596– 615 - PubMed
-
- American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29 ( Suppl. 1): S43– S48 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
